Skip to main content
Article
The use of 3′-deoxy-3′-18F-fluorothymidine (FLT) PET in the assessment of long-term survival in breast cancer patients treated with neoadjuvant chemotherapy
Annals of Nuclear Medicine (2019)
  • Benjamin E. Ueberroth, Wayne State University
  • Jawana M. Lawhorn-Crews, Wayne State University
  • Lance K. Heilbrun, Wayne State University
  • Daryn W. Smith, Karmanos Cancer Institute, Detroit, USA
  • Janice Akoury, Wayne State University
  • Rouba Ali-Fehmi, Wayne State University
  • Nicole T. Eiseler, Wayne State University
  • Nicole T. Eiseler, Cleveland Clinic
  • Anthony F. Shields, Wayne State University
Publication Date
June 1, 2019
DOI
10.1007/s12149-019-01345-w
Citation Information
Benjamin E. Ueberroth, Jawana M. Lawhorn-Crews, Lance K. Heilbrun, Daryn W. Smith, et al.. "The use of 3′-deoxy-3′-18F-fluorothymidine (FLT) PET in the assessment of long-term survival in breast cancer patients treated with neoadjuvant chemotherapy" Annals of Nuclear Medicine Vol. 33 Iss. 6 (2019) p. 383 - 393
Available at: http://works.bepress.com/nicole-eiseler/1/